Many successful drugs are based on medicinal plants used and stewarded for generations by Native communities. A UC Berkeley doctoral student says these communities should also benefit.
DUBTAC in action against a target. (Courtesy Nomura Lab)
For some time, scientists have been working on the major challenge of developing new therapies against many human diseases. Many of these diseases are caused by the abberant action of certain proteins in our cells that are considered “undruggable”, or difficult to therapeutically target using classical drug...
The catalysis innovator on the thrills of heading to the mountains and having a reaction named after him.
John Hartwig is the Henry Rapoport Professor of Chemistry at the University of California, Berkeley. He received the 2019 Wolf Prize in Chemistry. His research aims to find new metal-catalysed reactions, and he was one of the developers of the Buchwald-...
